New York City-based Mount Sinai Tisch Cancer Center has received the National Cancer Institute’s Comprehensive Cancer Center designation, the highest recognition granted to cancer centers in the U.S.
The center, founded in 2008, received an NCI Clinical Cancer Center designation in 2015, according to a news release from the health system.
Mount Sinai became eligible to apply for the comprehensive designation in 2024 following a decade of growth in clinical trials, research and community outreach.
Eric Nestler, MD, PhD, interim dean of the Icahn School of Medicine at Mount Sinai said in the release that the designation “underscores [Mount Sinai’s] sustained investment in cancer science, our commitment to training the next generation of investigators and our promise to improve cancer care not just here in New York, but nationally and globally.”
